Trauma-Induced Coagulopathy Management Techniques

Trauma-induced coagulopathy (TIC) arises early after severe injury and contributes substantially to mortality and morbidity. It encompasses a spectrum of haemostatic disturbances including impaired thrombin generation, platelet dysfunction and hyperfibrinolysis. Management has evolved from empirical transfusion towards balanced, goal-directed strategies that combine early use of antifibrinolytics, optimised blood product ratios and targeted factor supplementation. Point-of-care viscoelastic assays offer rapid insights into clot kinetics and stability, enabling individualised administration of fibrinogen concentrate, prothrombin complex concentrate and platelets. Protocols increasingly integrate clinical triggers, laboratory thresholds and dynamic monitoring to reduce preventable deaths and transfusion-related complications. Emerging approaches harness machine-learning models and cybermedical feedback systems to predict clot strength from protein concentrations, paving the way for automated, real-time coagulation control in the trauma setting. Global guidelines now emphasise time-critical interventions, multidisciplinary teamwork and continuous quality improvement to standardise care across diverse resource environments.

Research from Nature Portfolio

Recent studies have demonstrated that personalised, phenomenological models can accurately predict viscoelastic clot parameters from rapid measurements of blood protein concentrations. By mapping key plasma proteins to thromboelastography curves, these control-oriented models enable prediction of functional fibrinogen, native and platelet-mapping assays in minutes rather than the typical 20–30 minutes. Validation with trauma patient samples confirmed mechanistic fidelity and potential to inform automated transfusion and factor replacement systems. This work represents a step towards cybermedical platforms that continuously regulate coagulation status and tailor haemostatic interventions in real time.

Trauma-Induced Coagulopathy Management Techniques publication trend

The graph below shows the total number of articles in trauma-induced coagulopathy management techniques across all publications each year (not limited to Nature Index journals).

Technical terms

Trauma-induced coagulopathy (TIC): A complex haemostatic disorder following severe injury characterised by impaired clot formation and dysregulated fibrinolysis.

Viscoelastic assays: Point-of-care tests that measure the dynamics of clot initiation, formation and lysis in whole blood.

Thromboelastography (TEG): A technique that records clot strength and kinetics to guide targeted haemostatic therapy.

Thromboelastometry (ROTEM): A standardised form of viscoelastic testing providing rapid parameters of clot firmness and stability.

Fibrinogen concentrate: A purified plasma product used to restore critical fibrinogen levels in bleeding patients.

Prothrombin complex concentrate (PCC): A concentrated mixture of vitamin K–dependent clotting factors administered for rapid correction of coagulopathy.

References

1. Quick model-based viscoelastic clot strength predictions from blood protein concentrations for cybermedical coagulation control. Nature Communications (2024).
2. The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Critical Care (2023).
3. Strategic reuse of rapid antigen tests for coagulation status assessment: an integrated machine learning approach. Med-X (2024).
4. FIBTEM provides early prediction of massive transfusion in trauma. Critical Care (2011).
5. Detection of acute traumatic coagulopathy and massive transfusion requirements by means of rotational thromboelastometry: an international prospective validation study. Critical Care (2015).